Literature DB >> 19369455

The CPPDD-associated ANKH M48T mutation interrupts the interaction of ANKH with the sodium/phosphate cotransporter PiT-1.

John Wang1, Hing Wo Tsui, Frank Beier, Florence W L Tsui.   

Abstract

OBJECTIVE: Numerous dominant human homolog of progressive ankylosis (ANKH) mutations have been identified in familial calcium pyrophosphate dihydrate crystal deposition disease (CPPDD). Due to the dominant nature of these mutations, we investigated whether ANKH interacts with other proteins; and if so, whether any CPPDD-associated ANKH mutation might disrupt such protein interactions.
METHODS: Stable ATDC5 ANKH wt- and ANKH M48T-transfectants were generated. Lysates from these transfectants were used to identify candidate protein interaction with ANKH by coimmunoprecipitation followed by Western blot analysis. The effect of high phosphate on the expression of genes involved in modulating Pi (inorganic phosphate)/PPi (inorganic pyrophosphate) homeostasis in these transfectants was assessed.
RESULTS: We showed that ANKH protein associates with the sodium/phosphate cotransporter PiT-1, and that ANKH M48T mutant protein failed to interact with PiT-1. We also showed that upon high phosphate treatment, the normally coordinated upregulation of endogenous Ank and PiT1 transcript expression was disrupted in ANKH M48T transfectants.
CONCLUSION: Our results suggested that there is a coordinated interrelationship between 2 key participants of Pi and PPi metabolism, ANKH and PiT-1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19369455     DOI: 10.3899/jrheum.081118

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

Review 1.  Genetics and mechanisms of crystal deposition in calcium pyrophosphate deposition disease.

Authors:  Florence W L Tsui
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

Review 2.  Pathophysiology of articular chondrocalcinosis--role of ANKH.

Authors:  Abhishek Abhishek; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2010-11-23       Impact factor: 20.543

3.  Regulation of vascular smooth muscle cell calcification by extracellular pyrophosphate homeostasis: synergistic modulation by cyclic AMP and hyperphosphatemia.

Authors:  Domenick A Prosdocimo; Steven C Wyler; Andrea M Romani; W Charles O'Neill; George R Dubyak
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-16       Impact factor: 4.249

4.  The role of the progressive ankylosis protein (ANK) in adipogenic/osteogenic fate decision of precursor cells.

Authors:  Takeshi Minashima; Martin Quirno; You Jin Lee; Thorsten Kirsch
Journal:  Bone       Date:  2017-03-08       Impact factor: 4.398

Review 5.  The Role of ANK in Calcium Pyrophosphate Deposition Disease.

Authors:  Elizabeth Mitton-Fitzgerald; Claudia M Gohr; Brittany Bettendorf; Ann K Rosenthal
Journal:  Curr Rheumatol Rep       Date:  2016-05       Impact factor: 4.592

6.  Progressive ankylosis protein (ANK) in osteoblasts and osteoclasts controls bone formation and bone remodeling.

Authors:  Hyon Jong Kim; Takeshi Minashima; Edward F McCarthy; Jeffrey A Winkles; Thorsten Kirsch
Journal:  J Bone Miner Res       Date:  2010-08       Impact factor: 6.741

7.  Regulation of cell proliferation and cell density by the inorganic phosphate transporter PiT1.

Authors:  Kristina Byskov; Nina Jensen; Iben Boutrup Kongsfelt; Maria Wielsøe; Lasse Ebdrup Pedersen; Christa Haldrup; Lene Pedersen
Journal:  Cell Div       Date:  2012-03-06       Impact factor: 5.130

Review 8.  Extracellular pyrophosphate in the kidney: how does it get there and what does it do?.

Authors:  Shabbir H Moochhala
Journal:  Nephron Physiol       Date:  2012-10-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.